Centessa Pharmaceuticals-adr Share Price (NASDAQ: CNTA)

$16.78

▲

0.22

(1.33%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Centessa Pharmaceuticals-adr Stock chart to analyse performance

Centessa Pharmaceuticals-adr stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$16.38
Today's High:$16.82
$16.78
2.38%
Downside
Day's Volatility :2.62%
Upside
0.24%
52 Weeks Low:$9.60
52 Weeks High:$19.09
$16.78
42.79%
Downside
52 Weeks Volatility :49.71%
Upside
12.1%

Centessa Pharmaceuticals-adr Stock Returns

Period	Centessa Pharmaceuticals-adr	Sector (Health Care)	Index (Russel 2000)
3 Months	25.13%	3.6%	0.0%
6 Months	11.57%	-7.7%	0.0%
1 Year	24.3%	-12.6%	0.0%
3 Years	269.6%	9.5%	-4.7%

Centessa Pharmaceuticals-adr Key Stats

Check Centessa Pharmaceuticals-adr key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$16.56
Open	$16.56
Today's High	$16.82
Today's Low	$16.38
Market Capitalization	$2.2B
Today's Volume	$632.8K
52 Week High	$19.09
52 Week Low	$9.6
Revenue TTM	$15.0M
EBITDA	$-206.1M
Earnings Per Share (EPS)	$-1.85
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-72.92%

Stock Returns calculator for Centessa Pharmaceuticals-adr Stock including INR - Dollar returns

The Centessa Pharmaceuticals-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Centessa Pharmaceuticals-adr investment value today

Current value as on today

₹1,29,580

Returns

₹29,580

(+29.58%)

Returns from Centessa Pharmaceuticals-adr Stock

₹24,296 (+24.3%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Centessa Pharmaceuticals-adr Stock

14%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Centessa Pharmaceuticals-adr Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Centessa Pharmaceuticals-adr

Name
Holdings %
Name
Holdings %
Medicxi Ventures Management (Jersey) Ltd
14.91%
Index Venture Life Associates VI Ltd
7.44%
General Atlantic Llc
7.23%
Adage Capital Partners Gp LLC
5.19%
HHG PLC
4.88%
T. Rowe Price Associates, Inc.
4.41%

Analyst Recommendation on Centessa Pharmaceuticals-adr Stock

Rating

Trend

Buy

81%Buy

18%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Centessa Pharmaceuticals-adr(by analysts ranked 0 to 5 stars)

Centessa Pharmaceuticals-adr Share Price Target

What analysts predicted

Upside of 90.11%

Target:

$31.90

Current:

$16.78

Centessa Pharmaceuticals-adr share price target is $31.90, a slight Upside of 90.11% compared to current price of $16.78 as per analysts' prediction.

Centessa Pharmaceuticals-adr Stock Insights

Price Movement
In the last 3 years, CNTA stock has moved up by 306.3%
CNTA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 45.6%
Price to Sales
ForCNTA every $1 of sales, investors are willing to pay $144.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Centessa Pharmaceuticals-adr Technicals Summary

Sell

Neutral

Buy

Centessa Pharmaceuticals-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Centessa Pharmaceuticals-adr Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Centessa Pharmaceuticals-adr	-2.27%	11.57%	24.3%	269.6%	-23.48%
Regeneron Pharmaceuticals, Inc.	6.48%	-15.2%	-50.31%	-3.3%	-2.01%
Beone Medicines Ltd	1.77%	24.81%	62.78%	79.11%	29.69%
Vertex Pharmaceuticals Incorporated	-14.45%	-19.13%	-17.84%	34.68%	41.87%
Alnylam Pharmaceuticals, Inc.	13.79%	83.28%	75.87%	111.28%	242.25%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Centessa Pharmaceuticals-adr	NA	NA	NA	-1.38	-0.73	-0.29	NA	2.58
Regeneron Pharmaceuticals, Inc.	14.6	14.6	1.2	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.73	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.86	27.86	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Centessa Pharmaceuticals-adr	Buy	$2.2B	-23.48%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$61.4B	-2.01%	14.6	31.37%
Beone Medicines Ltd	NA	$36.5B	29.69%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.5B	41.87%	27.86	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$59.5B	242.25%	NA	-12.96%

About Centessa Pharmaceuticals-adr

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Organization	Centessa Pharmaceuticals-adr
Employees	98
CEO	Dr. Saurabh Saha M.D., Ph.D.
Industry	Healthcare

Key Management of Centessa Pharmaceuticals-adr

Name	Title
Dr. Saurabh Saha M.D., Ph.D.	CEO & Director
Mr. John J. Crowley CPA	CFO & Principal Financial Officer
Mr. Iqbal J. Hussain L.L.B.	General Counsel, Chief Compliance Officer & Corporate Secretary
Mr. Raphael Deferiere CPA	Chief Accounting Officer & Principal Accounting Officer
Ms. Tia L. Bush	Chief Technology & Quality Officer
Ms. Kristen K. Sheppard Esq., J.D.	Senior Vice President of Investor Relations & Corporate Communications
Ms. Karen M. Anderson	Chief People Officer
Dr. Gregory M. Weinhoff M.B.A., M.D.	Chief Business Officer
Dr. Mario Alberto Accardi Ph.D.	President of the Orexin Program
Ms. Charlene Stoudt	Senior Vice President of Clinical Development Operations

Important FAQs about investing in CNTA Stock from India :

What is Centessa Pharmaceuticals-adr share price today?

Centessa Pharmaceuticals-adr share price today is $16.78 as on August 30, 2025 at 1:29 am IST at the close of the market. Centessa Pharmaceuticals-adr share today touched a day high of $16.82 and a low of $16.38.

What is the 52 week high and 52 week low for Centessa Pharmaceuticals-adr share?

Centessa Pharmaceuticals-adr share touched a 52 week high of $19.09 and a 52 week low of $9.60. Centessa Pharmaceuticals-adr stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $16.78, lower by 12.1% versus the 52 week high.

How to invest in Centessa Pharmaceuticals-adr Stock (CNTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Centessa Pharmaceuticals-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Centessa Pharmaceuticals-adr Shares that will get you 0.0894 shares as per Centessa Pharmaceuticals-adr share price of $16.78 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Centessa Pharmaceuticals-adr Stock (CNTA) from India?

Indian investors can start investing in Centessa Pharmaceuticals-adr (CNTA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Centessa Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Centessa Pharmaceuticals-adr share’s latest price of $16.78 as on August 30, 2025 at 1:29 am IST, you will get 0.5959 shares of Centessa Pharmaceuticals-adr. Learn more about fractional shares .

What are the returns that Centessa Pharmaceuticals-adr has given to Indian investors in the last 5 years?

Centessa Pharmaceuticals-adr stock has given -23.48% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?